US2022111126A1PendingUtilityA1
Preventing biological tissue adhesion
Est. expiryMar 18, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61L 31/145A61L 31/047A61P 25/04A61P 15/00A61B 2017/00893A61B 2017/00823A61P 41/00A61P 29/00A61P 1/00A61L 31/16A61L 31/043
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and materials for mitigating biological tissue adhesion are described herein. One method for mitigating adhesion to a biological tissue includes administering an effective amount of a self-assembling peptide solution to the biological tissue, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions.
Claims
exact text as granted — not AI-modified1 . A method for mitigating adhesion to a biological tissue, the method comprising administering an effective amount of a self-assembling peptide solution to the biological tissue, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions, and wherein the hydrogel mitigates adhesion to the biological tissue.
2 . A method for mitigating adhesion between biological tissue, the method comprising administering an effective amount of a self-assembling peptide solution to a biological tissue at a surgical site, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions, and wherein the hydrogel mitigates adhesion of another biological tissue to the biological tissue at the surgical site.
3 - 40 . (canceled)Join the waitlist — get patent alerts
Track US2022111126A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.